1,279
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Factor 11 single-nucleotide variants in women with heavy menstrual bleeding

, , &
Pages 912-918 | Received 01 Dec 2015, Accepted 18 Mar 2017, Published online: 13 Jun 2017

References

  • Arellano AR, Bezemer ID, Tong CH, Catanese JJ, Devlin JJ, Reitsma PH, et al. 2010. Gene variants associated with venous thrombosis: confirmation in the MEGA study. Journal of Thrombosis and Haemostasis (JTH) 8:1132–1134.
  • Asakai R, Davie EW, Chung DW. 1987. Organization of the gene for human factor XI. Biochemistry 26:7221–7228.
  • Bezak A, Kaczanowski R, Dossenbach-Glaninger A, Kucharczyk K, Lubitz W, Hopmeier P. 2005. Detection of single nucleotide polymorphisms in coagulation factor XI deficient patients by multitemperature single-strand conformation polymorphism analysis. Journal of Clinical Laboratory Analysis 19:233–240.
  • Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, et al. 2008. Gene variants associated with deep vein thrombosis. JAMA 299:1306–1314.
  • Bicocchi MP, Rosano C, Acquila M. 2013. Genetic analysis in FXI deficient patients from northwestern Italy: three novel and one recurrent mutation. European Journal of Haematology 90:351–353.
  • Bolton-Maggs PH. 2009. Factor XI deficiency: resolving the enigma? Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009:97–105.
  • Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, et al. 2004. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. Journal of Thrombosis and Haemostasis (JTH) 2:918–924.
  • Bruzelius M, Bottai M, Sabater-Lleal M, Strawbridge RJ, Bergendal A, Silveira A, et al. 2015a. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors. Journal of thrombosis and haemostasis (JTH) 13:219–227.
  • Bruzelius M, Ljungqvist M, Bottai M, Bergendal A, Strawbridge RJ, Holmstrom M, et al. 2015b. F11 is associated with recurrent VTE in women. A prospective cohort study. Thrombosis and Haemostasis 115:406–414.
  • Castaman G, Giacomelli SH, Dragani A, Iuliani O, Duga S, Rodeghiero F. 2008. Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations. Haematologica 93:957–958.
  • Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, et al. 2012. Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis. British Journal of Haematology 157:753–761.
  • Davie EW, Fujikawa K, Kisiel W. 1991. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363–10370.
  • de Haan HG, Bezemer ID, Doggen CJ, Le Cessie S, Reitsma PH, Arellano AR, et al. 2012. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 120:656–663.
  • de Moerloose P, Germanos-Haddad M, Boehlen F, Neerman-Arbez M. 2004. Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis 15:269–272.
  • Delluc A, Gourhant L, Lacut K, Mercier B, Audrezet MP, Nowak E, et al. 2010. Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Thrombosis and Haemostasis 103:1161–1169.
  • El-Galaly TC, Severinsen MT, Overvad K, Steffensen R, Vistisen AK, Tjonneland A, et al. 2013. Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study. British Journal of Haematology 160:838–841.
  • Erdmann D, Heim J. 1995. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. The Journal of Biological Chemistry 270:22988–22996.
  • Erratum. 1999. Erratum for article of Martincic et al. in Blood. Blood 93:3309–3317. [1998 vol. 92(9):1786.]
  • Fard-esfahani P, Lari GR, Ravanbod S, Mirkhani F, Allahyari M, Rassoulzadegan M, et al. 2008. Seven novel point mutations in the F11 gene in Iranian FXI-deficient patients. Haemophilia 14:91–95.
  • Fujikawa K, Chung DW, Hendrickson LE, Davie EW. 1986. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 25:2417–2424.
  • FXI. 2014. FXI Deficiency Mutation Database. Available from: http://www.factorxi.org
  • Gerdes VE, Kraaijenhagen RA, Vogels EW, ten Cate H, Reitsma PH. 2004. Factor XI gene analysis in thrombophilia and factor XI deficiency. Journal of Thrombosis and Haemostasis (JTH) 2:1015–1017.
  • Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, et al. 2011. Genetics of venous thrombosis: insights from a new genome wide association study. PloS One 6:e25581.
  • Hanson E, Nilsson S, Jood K, Norrving B, Engstrom G, Blomstrand C, et al. 2013. Genetic variants of coagulation factor XI show association with ischemic stroke up to 70 years of age. PloS One 8:e75286.
  • Higham JM, O'Brien PM, Shaw RW. 1990. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology 97:734–739.
  • Hung HL, High KA. 1996. Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X. The Journal of Biological Chemistry 271:2323–2331.
  • Janssen CA, Scholten PC, Heintz AP. 1998. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid? European Journal of Obstetrics, Gynecology, and Reproductive Biology 78:69–72.
  • Jayandharan G, Shaji RV, Nair SC, Chandy M, Srivastava A. 2005. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val). Journal of Thrombosis and Haemostasis (JTH) 3:808–811.
  • Kim J, Song J, Lyu CJ, Kim YR, Oh SH, Choi YC, et al. 2012. Population-specific spectrum of the F11 mutations in Koreans: evidence for a founder effect. Clinical Genetics 82:180–186.
  • Knol HM, Mulder AB, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, Meijer K. 2013. The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities. American Journal of Obstetrics and Gynecology 209:202.e1–202.e7.
  • Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, Catanese JJ, et al. 2009. Genetic variants associated with deep vein thrombosis: the F11 locus. Journal of Thrombosis and Haemostasis (JTH) 7:1802–1808.
  • Lunghi B, Cini M, Legnani C, Bernardi F, Marchetti G. 2012. The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis. Thrombosis Research 130:563–564.
  • Martincic D, Zimmerman SA, Ware RE, Sun MF, Whitlock JA, Gailani D. 1998. Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting. Blood 92:3309–3317.
  • Meijers JC, Mulvihill ER, Davie EW, Chung DW. 1992. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 31:4680–4684.
  • Mitchell M, Cutler J, Thompson S, Moore G, Jenkins Ap Rees E, Smith M, et al. 1999. Heterozygous factor XI deficiency associated with three novel mutations. British Journal of Haematology 107:763–765.
  • Mitchell M, Harrington P, Cutler J, Rangarajan S, Savidge G, Alhaq A. 2003. Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high-performance liquid chromatography. British Journal of Haematology 121:500–502.
  • Mitchell M, Mountford R, Butler R, Alhaq A, Dai L, Savidge G, et al. 2006. Spectrum of factor XI (F11) mutations in the UK population-116 index cases and 140 mutations. Human Mutation 27:829.
  • Morange PE, Oudot-Mellakh T, Cohen W, Germain M, Saut N, Antoni G, et al. 2011. KNG1 Ile581Thr and susceptibility to venous thrombosis. Blood 117:3692–3694.
  • O'Connell NM. 2003. Factor XI deficiency: from molecular genetics to clinical management. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(Suppl 1):S59–S64.
  • O'Connell NM, Saunders RE, Lee CA, Perry DJ, Perkins SJ. 2005. Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. Journal of Thrombosis and Haemostasis (JTH) 3:127–138.
  • PROVEAN. 2014. Available from: http://provean.jcvi.org/index.php
  • Quelin F, Mathonnet F, Potentini-Esnault C, Trigui N, Peynet J, Bastenaire B, et al. 2006. Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis 17:69–73.
  • Quelin F, Trossaert M, Sigaud M, Mazancourt PD, Fressinaud E. 2004. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. Journal of Thrombosis and Haemostasis (JTH) 2:71–76.
  • Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. 1992. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proceedings of the National Academy of Sciences of the United States of America 89:6300–6303.
  • Reiner AP, Lange LA, Smith NL, Zakai NA, Cushman M, Folsom AR. 2009. Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. Journal of Thrombosis and Haemostasis (JTH) 7:1499–1505.
  • Rodeghiero F, Tosetto A, Castaman G. 2007. How to estimate bleeding risk in mild bleeding disorders. Journal of Thrombosis and Haemostasis 5(Suppl1):157–166.
  • Rovite V, Maurins U, Megnis K, Vaivade I, Peculis R, Rits J, et al. 2014. Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia. Thrombosis Research 134:659–663.
  • Sabater-Lleal M, Martinez-Perez A, Buil A, Folkersen L, Souto JC, Bruzelius M, et al. 2012. A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI Level and activated partial thromboplastin time. Arteriosclerosis, Thrombosis, and Vascular Biology 32:2008–2016.
  • Salloum-Asfar S, Teruel-Montoya R, Arroyo AB, Garcia-Barbera N, Chaudhry A, Schuetz E, et al. 2014. Regulation of coagulation factor XI expression by microRNAs in the human liver. PloS One 9:e111713.
  • Sato I, Nakayama T, Maruyama A, Furuya K, Sato N, Mizutani Y, et al. 2006. Study of association between hypertensive disorders of pregnancy and the human coagulation factor XI gene. Hypertension in Pregnancy 25:21–31.
  • Saunders RE, Shiltagh N, Gomez K, Mellars G, Cooper C, Perry DJ, et al. 2009. Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency. Thrombosis and Haemostasis 102:287–301.
  • Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, et al. 2007. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 297:489–498.
  • Smith NL, Wiggins KL, Reiner AP, Lange LA, Cushman M, Heckbert SR, et al. 2009. Replication of findings on the association of genetic variation in 24 hemostasis genes and risk of incident venous thrombosis. Journal of Thrombosis and Haemostasis (JTH) 7:1743–1746.
  • Sokol J, Biringer K, Skerenova M, Stasko J, Kubisz P. 2014. Activity of coagulation factor XI in patients with spontaneous miscarriage: The presence of risk alleles. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology 35:621–4.
  • Sun M, Baglia FA, Ho D, Ware RE, Walsh PN, Gailani D. 2001. Defective binding of factor XI-N248 to activated human platelets. Blood 98:125–129.
  • Tang W, Schwienbacher C, Lopez LM, Ben-Shlomo Y, Oudot-Mellakh T, Johnson AD, et al. 2012. Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. American Journal of Human Genetics 91:152–162.
  • Tang W, Teichert M, Chasman DI, Heit JA, Morange PE, Li G, et al. 2013. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genetic Epidemiology 37:512–521.
  • Tarumi T, Kravtsov DV, Moore JH, Williams SM, Gailani D. 2003. Common single nucleotide polymorphisms in the promoter region of the human factor XI gene. Journal of Thrombosis and Haemostasis: JTH 1:1854–1856.
  • Tarumi T, Kravtsov DV, Zhao M, Williams SM, Gailani D. 2002. Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) is required for hepatocyte-specific expression of factor XI. The Journal of Biological Chemistry 277:18510–18516.
  • Tarumi T, Martincic D, Whitlock JA, Addy JH, Williams SM, Gailani D. 2000. Conserved worldwide linkage disequilibrium in the human factor XI gene. Genomics 70:269–272.
  • van Hylckama Vlieg A, Flinterman LE, Bare LA, Cannegieter SC, Reitsma PH, Arellano AR, et al. 2014. Genetic variations associated with recurrent venous thrombosis. Circulation Cardiovascular Genetics 7:806–813.
  • Ventura C, Santos AI, Tavares A, Gago T, Lavinha J, McVey JH, et al. 2000. Molecular genetic analysis of factor XI deficiency: identification of five novel gene alterations and the origin of type II mutation in Portuguese families. Thrombosis and Haemostasis 84:833–840.
  • Zadra G, Asselta R, Malcovati M, Santagostino E, Peyvandi F, Mannucci PM, et al. 2004. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica 89:1332–1340.
  • Zadra G, Asselta R, Tenchini ML, Castaman G, Seligsohn U, Mannucci PM, et al. 2008. Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians. Haematologica 93:715–721.
  • Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, et al. 2002. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 99:2448–2454.